This guide covers the recognised symptoms of perimenopause and menopause, the myths about HRT that keep too many women out of treatment, and what to do if any of it sounds like you. It isn't a substitute for an appointment, but it is a head start on one.
Could it be your hormones?
Most women start experiencing symptoms of perimenopause in their early 40s, often before periods change at all. These are the clusters that bring women to the clinic most often.
Symptoms by category.
Around forty distinct symptoms are now recognised. Most women experience clusters from three or four of the categories below.
- Sudden flushes lasting one to five minutes, often peaking late afternoon or 4am
- Night sweats, soaked sheets, broken sleep, secondary fatigue
- Palpitations, particularly on waking — heart beating loud or fast without explanation - women can worry its a heart problem or anxiety
- Skin flushing without a temperature change
Most responsive to: oestrogen replacement, with effect typically by 6-12 weeks. CBT and SSRIs are useful alternatives where HRT isn't an option.
Patients think they have early dementia or are told its due to stress
- Word-finding difficulty, particularly nouns
- Short-term memory lapses (walking into rooms, forgetting names)
- Loss of mental sharpness or “executive function” at work
- Difficulty multi-tasking or holding several threads at once
The good news: these are reversible. Patients often report cognitive return within 8-12 weeks of starting appropriate HRT.
Frequently misdiagnosed as primary depression or anxiety.
- New-onset anxiety, often physical (chest tightness, racing thoughts)
- Loss of resilience, small things feel disproportionate
- Feeling angry, snapping at others
- Tearfulness with no identifiable trigger
HRT is often the first-line treatment because it addresses the underlying hormonal changes driving these symptoms. Antidepressants can still play an important role for some women and may be used alongside HRT where appropriate, but in most cases they should not be offered as a substitute for HRT alone.
Sleep disturbance can be one of the most disruptive symptoms of perimenopause and menopause, affecting not only your quality of life but often intensifying other symptoms too. This may show up as:
- Difficulty falling asleep, often alongside a sense of night-time anxiety
- Waking in the early hours, particularly around 3-4am, and struggling to get back to sleep
- Night sweats
- New-onset restless legs
Oral micronised progesterone is usually taken at night for good reason. It has mild sedative properties, and for many women it is one of the first parts of HRT to make a noticeable difference.
Declining oestrogen levels can have a significant impact on muscles and joints, this is sometimes mislabelled as fibromyalgia.
- Joint stiffness
- Generalised aching, especially across the neck, shoulders, and lower back
- Frozen shoulder (adhesive capsulitis), which is disproportionately common in women between the ages of 45 and 55
- Plantar fasciitis or newly developed heel pain
Bone health is equally important to consider. Bone density can fall more rapidly during the first decade after menopause, often without any obvious symptoms until the damage is done. For appropriate women, HRT remains the most effective treatment available to help prevent osteoporosis, a longer-term benefit that is often underappreciated when weighing up the decision to start treatment.
Falling oestrogen levels affect not only the reproductive tissues but also the lining of the urinary tract, giving rise to a condition known as Genitourinary Syndrome of Menopause, or GSM. Unlike many perimenopausal symptoms, GSM does not ease with time. Without treatment, it typically worsens. This can present as:
- Vaginal dryness and discomfort during sex
- Recurrent urinary tract infections
- Urinary urgency or increased frequency
- Vulval itching or a persistent burning sensation
These symptoms are common, often deeply affecting quality of life and intimacy, and yet many women feel too embarrassed to raise them, or are simply not aware that effective treatment exists.
Vaginal oestrogen is highly effective and well tolerated and can be used long term with confidence, if you have been silently managing these symptoms please talk about it. If you have been given repeated courses of antibiotics for recurrent UTI's make sure you have a conversation regarding topical oestrogen with your doctor.
- Skin thinning and loss of elasticity (collagen loss is 30% in the first five years)
- Adult-onset acne, particularly along the jawline
- Hair thinning at the crown
- Central weight gain, even without dietary change
- Itchy skin or new sensitivities
Systemic HRT can help address many of these changes from the inside out. Alongside this, resistance training and a diet that prioritises adequate protein can make a significant difference to body composition, skin quality, and overall resilience, changes that compound positively over time when started early.
Hormonal fluctuations during perimenopause can trigger migraines for the first time, or significantly worsen them in women who have always been susceptible. For many, this comes as an unwelcome surprise, migraines that seem to appear from nowhere, or familiar ones that suddenly become more frequent and harder to manage.
The connection is well established. Oestrogen levels that rise and fall erratically, as they do during perimenopause, are a potent migraine trigger. Transdermal HRT, delivered usually through a patch rather than taken orally, helps to stabilise these fluctuations, and for many women this can lead to a meaningful reduction in both the frequency and severity of migraines.
If you have noticed a change in your headache pattern alongside other perimenopausal symptoms, it is worth discussing. This is rarely a coincidence, and it is rarely something you simply have to put up with.
A reduced sex drive is one of the most common, and least openly discussed, symptoms of perimenopause. It can quietly affect quality of life and intimate relationships, yet many women feel reluctant to raise it, or are simply not aware that it has a hormonal basis and a range of effective treatments.
The causes are rarely straightforward. Falling oestrogen, declining testosterone, vaginal discomfort, low mood, and the cumulative exhaustion of managing multiple symptoms can each play a role, and often several of these are at work simultaneously.
The first step is to ensure that other symptoms are well managed with HRT, as this alone can make a meaningful difference to libido. Optimising oestrogen levels can also lead to a natural rise in your own testosterone, and for many women, this is sufficient. If reduced sex drive persists once everything else is optimised, additional testosterone supplementation may then be considered.
It is also worth knowing that Hypoactive Sexual Desire Disorder, a persistent and distressing reduction in sexual desire, is a recognised medical condition. It is not simply something to accept as an inevitable consequence of midlife, and it is an entirely legitimate reason to seek support.
If this is something you have been putting off discussing, please know that it will be received without judgement. It matters, and there is help available.
It's very common for your periods to change during this transition; they may become shorter or longer, heavier or lighter. If you are experiencing disruptive or dysfunctional bleeding, please know there are effective treatment options available. We can use progesterone as part of HRT in a sequential pattern to try and regulate the bleeding or consider a Mirena coil, which is an exceptionally effective tool for managing heavy and painful period.
This is not something you simply have to endure. Please seek help to get the support you need.
HRT: what to believe.
The risk is real but it is small, and it depends entirely on the type of HRT. Combined oestrogen + progestogen HRT carries a small additional risk of breast cancer of around four extra cases per 1,000 women over five years of use. Oestrogen-only HRT (for women without a uterus) carries no increased risk.
For context: drinking two units of alcohol a day carries a similar risk. Being overweight carries a substantially higher one. HRT remains a small, well-quantified risk that should be weighed against quality of life and the cardiovascular, bone, and cognitive benefits.
It doesn't. Your ovaries continue their decline regardless of whether you're on HRT. What HRT does is replace the hormones you're losing while you go through the transition, then provide protection against the long-term consequences of low oestrogen.
Women often stay on HRT into their 70s and beyond, and current guidance supports this where the benefits outweigh risks for the individual. There is no arbitrary stop date.
For most women over 45, the answer is no. NICE guidelines are explicit: if you are over 45 and experiencing typical symptoms, perimenopause is a clinical diagnosis, meaning we listen to you, rather than relying on a test result. In fact, hormone testing at this stage can be actively misleading. Because hormones like FSH fluctuate dramatically during perimenopause, a normal blood test on a random day tells us very little about the broader picture. While blood tests remain an important tool, it's the conversation that truly matters: understanding exactly how you are feeling and designing the right plan to manage it.
It's a meaningful term, but a narrower one than most websites suggest. Body-identical HRT means hormones with the same molecular structure as those your body produces (17β-oestradiol and micronised progesterone). These are regulated, licensed products available on the NHS.
This is different from “bio-identical” HRT, which usually refers to compounded hormones from private pharmacies. Those are unregulated, the doses are not standardised, and they are not recommended by any UK menopause body.
You generally can, though the risk/benefit conversation shifts. Starting HRT within ten years of menopause carries the best cardiovascular profile. Starting later is not contraindicated, but the route (transdermal preferred) and dose need careful tailoring.
For urogenital symptoms, vaginal oestrogen has no age limit and can be started at any time.
It doesn't, and in some studies it modestly redistributes weight away from the abdomen. Menopause itself drives central weight gain through changes in fat distribution, insulin sensitivity, and muscle mass. HRT can blunt some of that, but it's not a weight-loss tool.
The most effective interventions for midlife weight are resistance training, protein-prioritised eating, and addressing sleep, which HRT also helps.
Oral oestrogen carries a small increase in VTE risk. Transdermal oestrogen (patches, gels, sprays) does not, because it bypasses first-pass liver metabolism. This is why transdermal is now first-line for the vast majority of women starting HRT.
Women with a personal or strong family history of clots can almost always still have HRT. They just need transdermal, micronised progesterone, and a proper risk discussion.
By all means try, but go in with realistic expectations. Black cohosh, red clover, evening primrose oil, and most “menopause supplements” have either no evidence or evidence of no effect beyond placebo. CBT has reasonable evidence for hot flushes. Soy isoflavones have modest evidence.
The “natural first” framing assumes HRT is unnatural, but the oestrogen in modern HRT is bio-identical, and untreated menopause is not the body's default state. It's the body without a hormone it used to have.
What to do next.
Check your symptoms
Fill out a symptom questionnaire - available widely online or you can download from the website, very useful to take to your first appointment.
Speak to your NHS GP
Many women get excellent care on the NHS, particularly with women's health champions in the practice. Try that route before private.
Book private if needed
If the NHS route has stalled, or you want a longer consultation and second opinion, that's exactly what this practice is for.
Check your symptoms
Fill out a symptom questionnaire - available widely online or you can download from the website, very useful to take to your first appointment.
Download Symptom TrackerReady for an appointment
Frequently Asked Questions
Perimenopause is the transitional phase before menopause, when oestrogen levels begin to fluctuate and symptoms such as irregular periods, hot flushes, mood changes and brain fog can start, typically in your early to mid-40s. Menopause is reached when your periods have stopped for 12 consecutive months, usually around age 51 for Caucasian women and 46 to 48 for South Asian women. Many women experience their most significant symptoms during perimenopause, before menopause is officially reached.
Perimenopause can be difficult to recognise because symptoms vary widely and are often attributed to stress, busy lifestyles, or other conditions. Common signs include irregular periods, hot flushes, night sweats, low mood, anxiety, fatigue, brain fog, joint aches and changes in libido. If you are over 45 and experiencing these symptoms, perimenopause is likely. A consultation with a menopause-trained GP can help you connect the dots and explore your options.
Not necessarily. If you are over 45 and your symptoms are consistent with perimenopause, a diagnosis can be made on clinical grounds without blood tests. Blood tests can be useful in certain circumstances, such as if you are under 45 or your symptoms are atypical. During your consultation I will advise whether testing is appropriate in your specific situation.
For most women, modern HRT is safe and the benefits outweigh the risks. Much of the concern around HRT stems from a 2002 study that has since been significantly revised. The small increased risk of breast cancer associated with combined HRT is comparable to the risk from drinking two glasses of wine daily. Transdermal HRT (patches, gels, or sprays), which is my preferred approach, does not increase the risk of blood clots. I will discuss your individual risk profile with you in detail during your consultation.
There is no arbitrary time limit. The decision to continue HRT should be reviewed regularly and based on your ongoing symptoms, personal preferences and individual risk profile. Many women safely use HRT for 10 years or longer, and some continue into their 60s and beyond. I will review your treatment at each follow-up appointment and support you in making an informed decision.
Yes, and I would encourage you to ask them. If your NHS surgery has a GP with an interest in women's health or menopause, they may be able to prescribe HRT for you long term, which is the most cost-effective route. I am happy to start your treatment privately and provide a full summary letter so your NHS GP can continue your prescription. If your NHS GP is unwilling or unable to help, I am of course happy to continue your care privately.
Your new patient consultation (45 minutes, £245) includes a full assessment of your symptoms and their impact on your daily life, a review of your medical and family history, blood pressure and weight check, guidance on whether blood tests are indicated, a clear discussion of HRT options including risks and benefits, and a personalised management plan. If HRT is appropriate, I can issue a private prescription at the end of the appointment.
Yes. All consultations, including new patient appointments and follow-ups, are available face to face in Iver, Buckinghamshire, or remotely via video. Appointments are generally Wednesday to Saturdays. Please see the booking link for availability.